MedTrace Logo

CPP Versus PFC to Correct Coagulation Disorders in Adult Neurosurgical Patients

NCT02777424 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2024-06-05

No results posted yet for this study

Summary

This prospective, randomized, multicenter study is performed to determine whether prothrombin complex concentrates confers any benefits over fresh frozen plasma in adult neurological patients with coagulation disorders (PT value less than 60%).

Conditions

  • Intracranial Hemorrhages

Interventions

DRUG

Prothrombin Complex Concentrate

Non-activated prothrombin complex concentrate containing factors II, VII, IX and X and proteins C \& S

BIOLOGICAL

Fresh Frozen Plasma

Pooled collection of plasma from donors

Sponsors & Collaborators

  • Fondation Ophtalmologique Adolphe de Rothschild

    lead NETWORK

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-21
Primary Completion
2019-03-27
Completion
2019-03-27

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02777424 on ClinicalTrials.gov